Nova Patents
PL373301A1

Phosphodiesterase 4 inhibitors

Abstract

PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula (I): wherein R<1>, R<2>, R<3> and R<4> are as defined herein.

Term

Term ended

Projected expiry passed 22 January 2022, 4.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

12 priority claims, no other members on record

This recordMember, by publication datePriority claim

Priority claims12

Priority claims
DocumentOfficeKindDate
26265101United States of AmericaP
26265101United States of AmericaP
26719601United States of AmericaP
26719601United States of AmericaP
30614001United States of AmericaP
30614001United States of AmericaP
0160262651–––
0160267196–––
0160306140–––
US20010262651P–––
US20010267196P–––
US20010306140P–––